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Abstract. In melanocytes and in melanoma cells, up- 
regulation of melanogenesis, by cAMP elevating 
agents, results from a stimulation of tyrosinase activity 
that has been ascribed to an increase in tyrosinase pro- 
tein and messenger amount. However, the mechanism 
by which cAMP elevating agents increase tyrosinase 
mRNA remains to be elucidated. In this study, using a 
luciferase reporter plasmid containing the 2.2-kb frag- 
ment 5' of the transcriptional start site of the mouse ty- 
rosinase gene, we showed that cAMP elevating agents 
lead to a strong stimulation (20-fold) of transcriptional 
activity of the tyrosinase promoter. Deletions and mu- 
tations in the mouse tyrosinase promoter showed that 
the M-box 70-bp upstream from the TATA-box and 
the E-box located downstream the TATA-box, near to 
the initiator site, are involved in the regulation of the 
tyrosinase promoter activity by cAMP. Additionally, 
we showed that microphthalmia, a b-HLH transcription 
factor associated with pigmentation disorders in mouse, 
binds to these regulatory elements and modulates the 
transcriptional activity of the tyrosinase promoter. 
Since cAMP stimulates the binding of microphthalmia 
to the M-box and to the E-box; it is tempting to pro- 
pose that microphthalmia, through its interaction with 
cis-acting elements surrounding the TATA-box, plays a 
key role in the regulation of the mouse tyrosinase gene 
expression by cAMP. 
S 
KtN  melanocytes  originate  from  the  neural  crest, 
from which they migrate into the basal layer of epi- 
dermis  and  proliferate  as  precursor  melanoblasts 
(Le Douarin, 1982). Subsequently, these cells differentiate 
to melanin-producing  melanocytes and acquire a specific 
enzymatic machinery  responsible  for melanin  synthesis. 
Tyrosinase,  the  rate-limiting  enzyme  in  melanogenesis, 
catalyzes the two initial  steps of this process, hydroxyla- 
tion of tyrosine to 3,4-dihydroxyphenylalanine  (DOPA)  1 
and oxidation of DOPA to DOPA quinone (Hearing and 
Jimenez,  1987; Prota,  1988; Hearing  and  Jimenez,  1989; 
Hearing and Tsukamoto, 1991). Two other enzymes, tyro- 
sinase-related  protein  1  (TRP-1),  possessing a  5,6-dihy- 
droxyindole-2-carboxylic acid  (DHICA) oxidase activity 
(Kobayashi et al.,  1994) and tyrosinase-related protein 2 
(TRP-2) endowed with a DOPA chrome tautomerase ac- 
tivity (Jackson et al., 1992; Kameyama et al., 1993; Yoko- 
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1. Abbreviations used in this paper: CTx, cholera toxin; DOPA, 3,4-dihy- 
droxyphenylalanine; b-HLH, basic-helix-loop-helix; IBMX, isobutylmeth- 
ylxanthine; aMSH, amelanocyte-stimutating hormone; pRB, retinoblas- 
toma protein; SV40, simian virus 40; TRP, tyrosinase-related protein. 
yama et al., 1994a) are involved in melanin production (Ab- 
del-Malek et al., 1993). The expression of these enzymes is 
restricted to melanocytes, suggesting  the presence in their 
promoter  of regulatory  elements  responsible for  tissue- 
specific expression. Sequencing of TRP-1, TRP-2, and ty- 
rosinase promoters has revealed the presence of a  10-bp 
sequence  (GTCATGTGCT)  termed  the  M-box,  which 
was  thought  to  be  involved  in  cell-specific  expression 
(Lowings et al., 1992; Ganss et al., 1994; Yokoyama et al., 
1994b). The CATGTG motif matches with the core hex- 
amer sequence CANNTG (E-box) that is recognized by 
the  basic-helix-loop-helix  (b-HLH)  transcription  factor 
family.  This  transcription  factor family includes  ubiqui- 
tously expressed proteins such as myc, max (Blackwood 
and  Eisenman,  1991), upstream  stimulatory factor, USF 
(Gregor  et  al.,  1990),  and  tissue-specific expressed pro- 
teins  such as myogenic factors  (Edmondson  and  Olson, 
1993).  Recently, pigmentation  disorders  observed in  mi- 
crophthalmic mouse have been associated with mutations 
of  a  b-HLH  transcription  factor  encoded  by  the  mi- 
crophthalmia gene (Hodgkinson et al., 1993; Hughes et al., 
1993).  Similarly,  MITF,  the  human  homologue  of  the 
mouse microphthalmia gene, has been linked to abnormal 
pigmentation observed in Waardenburg Syndrome type 2 
(Hughes et al., 1994). 
In vivo or in cultured cells, melanogenesis can be stimu- 
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1987;  Agin  et  al.,  1991; Aberdam  et  al.,  1993)  and  by 
cAMP elevating agents such as forskolin, a direct activator 
of adenylate cyclase, Isobutylmethylxanthine (IBMX),  a 
phosphodiesterase inhibitor, and a melanocyte stimulating 
hormone (aMSH) that activates adenylate cyclase through 
the  binding  to  a  receptor  coupled  to  as  (Wong  and 
Pawelek, 1975; Hunt et al., 1993). Upregulation of melano- 
genesis by cAMP elevating agents results from a stimula- 
tion of tyrosinase activity that has been ascribed to an aug- 
mentation of tyrosinase protein  and messenger amount 
(Aroca et al., 1993; Kuzumaki et al., 1993).  The mecha- 
nism by which cAMP elevating agents increase tyrosinase 
mRNA remains controversial. Indeed, it has been recently 
proposed  that  the  regulation  of  tyrosinase  mRNA  by 
cAMP occurs by a posttranscriptional mechanism such as 
mRNA stabilization (Ganss  et  al.,  1994).  On  the other 
hand, the augmentation of tyrosinase expression by otMSH 
was inhibited by ot-amanitin suggesting a  transcriptional 
regulation of the tyrosinase gene expression (Fuller et al., 
1987). Sequencing of the 5'-flanking region of the mouse 
tyrosinase gene has failed to identify canonical cAMP re- 
sponsive elements (CRE) (Borrelli et al., 1992). Neverthe- 
less, other enhancer elements such as ultraviolet respon- 
sive element (URE) (Ronai et al., 1994), TPA responsive 
element (TRE) (Angel et al., 1987), and AP2-binding se- 
quence (Imagawa et al., 1987) have been found in the tyro- 
sinase promoter and might be the target of transcription 
factors activated following the rise of the cAMP content in 
melanocytes. 
In this report, we first investigated whether cAMP regu- 
lates the mouse tyrosinase gene expression through a tran- 
scriptional mechanism. In this aim, we constructed a  re- 
porter  plasmid containing the 2.2-kb fragment 5'  of the 
transcriptional start site of the mouse tyrosinase gene. We 
showed that cAMP increases the transcriptional activity of 
the mouse tyrosinase promoter. A  M-box 70-bp upstream 
from the TATA-box and the E-box located downstream 
the TATA-box, near to the initiator site, are involved in 
the regulation of the tyrosinase promoter activity by cAMP. 
Moreover, our data suggest that microphthalmia, through 
the binding to these regulatory elements, mediates the ef- 
fect of cAMP on the tyrosinase gene expression. 
Materials and Methods 
Materials 
Dulbecco's modified Eagles medium (DMEM), 4-norleucine 7-D-phenylai- 
anine-~x-melanocyte stimulating hormone ([Nle  4, D-PheT]-etMSH),  IBMX, 
forskolin, bovine serum albumin (BSA), 4-(2-aminoethyl)-benzene-sulfo- 
nyl fluoride  (AEBSF),  aprotinin,  and  leupeptin were  purchased from 
Sigma Chem. Co. (St. Louis, MO). "y-[3zP]ATP (3,000 Ci/mmol) was from 
Amersham Corp. (Arlington Heights, IL) and lipofectamine reagent from 
GIBCO-BRL (Gaithersburg, MD). Klenow fragment, T4 polynucleotide 
kinase, and T4 DNA ligase were from Biolabs, Synthetic oligonucleotides 
were purchased from Genset or Oligo express. Anti-microphthalmia anti- 
body was obtained by injection of a rabbit with a peptide (NH2-T-S-S-R- 
R-S-S-M-S-A-E-E-T-E-H-A-C-COOH)  corresponding to the COOH ter- 
minus part of mierophthalmia (Hodgkinson et al., 1993) coupled to key- 
hole limpet hemocyanine. 
Cell Cultures 
B16/F10  murine melanoma cells (from Dr. V.J. Hearing, NIH, Bethesda, 
MD), $91 murine melanoma cells and NIH3T3 fibroblast cells were grown 
at 37°C under 5% CO2 in DMEM supplemented with 10% FCS and 100 
U/ml penicillin/streptomycin. G361  human melanoma cells were grown 
under the same conditions in Mc Coy's medium. 
Transfections and Luciferase Assays 
B16 melanoma cells, in 24-well dishes, were transfected with 0.25  p,g of 
the test plasmid and 0.05 I~g of pCMVI~Gal to control the variability in 
transfection efficiency, using 2 p,l of lipofectamine in a 200-p,l final vol- 
ume. In the experiences with microphthalmia the transfection was per- 
formed in the same conditions using, 0.25 Ixg of the test plasmid, 0.01 Ixg of 
pCMVI3Gal, and 0.04  p,g of pCDNA3 expression vector, empty or con- 
taining the microphthalmia coding sequence. After 6 h, the transfection 
medium was changed and  the cells were incubated with the different 
cAMP elevating agents for the indicated time. Then, cells were washed 
with a saline phosphate buffer and lysed with 25 mM Tris-phosphate (pH 
7.8) buffer containing 1% Triton X-100, 2 mM EDTA, and 2 mM DTI'. 
Soluble extracts were harvested and assayed for luciferase and 13-galac- 
tosidase activity. All transfections were repeated at least five times using 
different plasmid preparations and gave similar results. To obtain stably 
transfected B16 cells, we used a 10:1 molar ratio of pMT2.2 or pMT0.27 
and pCDNA3. Stable transfected B16 cells were selected in medium con- 
taining 800 ~g/ml G418. Individual clones were isolated and characterized 
after 3 wk. NIH3T3 cells stably expressing microphthalmia were obtained 
by transfection with pCDNA3 encoding microphthalmia and  selection 
with 500  Ixg/ml G418.  Individual clones were isolated and characterized 
after 3 wk. 
Construction of the Reporter Plasmid 
A 2.2-kb fragment 5' of the transcriptional start site of the mouse tyrosi- 
nase gene was isolated from mouse genomic DNA by polymerase chain 
reaction  (PCR)  using  the  following primers:  5'-TTCAACCC'I'I'I'FC- 
TATGTCC-3' (-2236/-2217)  and 5'-TCATACAAgATCTGCACCAA- 
3' (+63/+42). The transcription initiation site was numbered +1 accord- 
ing to the report of Kikuchi et ai. (1989).  BglII recognition site was intro- 
duced in the lower primer to facilitate the cloning. The PCR product was 
initially introduced into the TA cloning vector and sequenced (Invitrogen, 
Deschelp,  Netherlands).  Subsequently,  the  XhoI-BglII  fragment  was 
cloned into the unique XhoI-Bglll sites of pGL2-basie vector (PGL2B), 
upstream the luciferase coding sequence (pMT2.2; -22361+59). Two de- 
letion plasmids, pMT1.8  (-1789/+59)  and pMT1.3  (-1317/+59),  were 
obtained  by  exonuclease  III  digestion using  the  Erase-a-base  system 
(Promega, Madison, WI). For the other deletions, pMT2.2 was first linear- 
ized with KpnI, and then digested with either NcoI, AvrII, or NsiL Plas- 
raids were filled in with Klenow fragment and self-ligated  with T4 DNA li- 
gase, giving respectively the following plasmids: pMTI.1  (-1100/+59), 
pMT0.9 (-986/+59), and pMT0.5 (-517/+59). pMT0.27 (-270/+59) was 
obtained by subcloning the 270-base pairs (bp) XbaI-BglII fragment of 
the mouse tyrosinase gene, into the NheI-BglII sites of pGL2B, pMT0.08 
(-80/+59) was constructed by subcloning the HindIII (converted to blunt 
end)-BglfI fragment isolated from pMT0.27 into the SmaI-BglII sites of 
pGL2B. The 2.2-kb fragment (XhoI-BglII) 5' of the transcriptional start 
site of the mouse tyrosinase gene was also cloned into the unique XhoI- 
BglII sites of pGL2-promoter vector (PGI.~P) which contains the simian 
virus 40 (SV40) enhancerless early promoter linked to the luciferase gene 
(pSVMT2.2).  pMT0.1  (-126/+59)  was  constructed  by  subcloning the 
RsaI-BglII restriction fragment isolated from pSVMT2.2 into the unique 
SmaI-BglII sites of pGI_~B, pMTA0.1 and pMT0.04 and all the mutants 
were constructed with the Transformer  TM  site-directed mutagenesis kit 
(Clontech, Palo Alto, CA). Deletions and mutations of all constructs were 
verified by plasmid sequencing. A  eDNA encoding the microphthalmia 
gene product was isolated by reverse transcription of B16 melanoma cell RNA 
and PCR using the following  primers: 5'AAGTGGTC'rGCGGTGTC'TCC3' 
and 5'AAGGCAGGCTCGCTAACACG3'. The PCR product (1.3  kb) 
was initially cloned into pSKbluescript and sequenced. A clone that was 
found to be 100%  identical to the published microphthalmia sequence 
(Hodgkinson et al.,  1993) was then inserted as a HindIII-Notl restriction 
fragment into the unique HindIII-NotI sites of the pCDNA3 expression 
vector. All constructs were purified using the silica column from Quiagen 
(Hylden, Germany). 
lmmunofluorescence Studies 
Cells were washed with PBS and fixed at -20°C for 10-rain with metha- 
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containing 3% BSA (PBS/BSA), fixed cells were incubated with the pri- 
mary antibody directed to the COOH terminus part of microphthalmia 
for 60 min at 25°C. Cells were then washed five times with PBS/BSA and 
incubated in PBS/BSA for 60 min at 25°C with fluorescein isothiocyanate- 
conjugated  secondary antibody  (anti-rabbit,  1:100).  Finally, cells were 
washed five times with PBS/BSA and examined with a Zeiss Axiophot mi- 
croscope. 
In Vitro Transcription and Translation 
In vitro translations of microphthalmia were carried out using the linked 
T7 transcription-translation system from Amersham. Microphthalmia trans- 
lation was monitored using [35S]methionine and SDS-PAGE analysis. 
Nuclear Extracts and Gel Mobility Shift Assay 
B16 cells were stimulated with forskolin and the nuclear extracts were 
prepared essentially as previously described (Dignam et al., 1983).  Dou- 
ble-stranded synthetic M-box, 5'-GAAAAAGTFAGTCATGTGCTITGC- 
AGAAGA-3' or iE-box 5'-GGTCTlrAGCCAAAACATGTGATAGT  - 
CACTCCAG-3' was ,/32p end-labeled with the T4 polynucleotide kinase. 
10 }xg of nuclear proteins or 4 p.l of the in vitro translated microphthalmia 
were preincubated in binding buffer containing 10 mM Tris, pH 7.5,  100 
mM NaCI, 1 mM DTT, 1 mM EDTA, 4% glycerol, 80 jxg/ml of salmon 
sperm DNA, 0.5 l~g poly (dIdC), 0.2%  BSA, 2 mM MgC12, and 2  mM 
spermidine for 30 min at room temperature. Then, 150,000-200,000 cpm 
of 32p probe was added to the reaction mixture for 20 min at 37°C. DNA- 
protein  complexes were  resolved by electrophoresis on  5%  polyacryl- 
amide gel (37.5:1  Acrylamide-Bisacrylamide) in TAE buffer (10 mM "Iris, 
9 mM sodium acetate/acetic acid, 275 mM EDTA, pH 8) for 6 h at 150 V. 
When indicated, an excess of cold competitor oligonucleotides was added 
during preincubation. In mutated M-box and iE-box the CATGTG motif 
was converted to CGGATC. For supershift assays, the antibodies were 
preincubated with nuclear extracts in binding reaction buffer for 60 rain 
before adding the labeled probe. 
Results 
Regulation of  Mouse Tyrosinase Promoter Activity by 
cAMP Elevating Agents 
Initially, a  plasmid containing  the  2.2-kb 5'  of the  tran- 
scriptional  start  site  of  the  mouse  tyrosinase  gene  up- 
stream from the firefly luciferase coding sequence (pMT2.2; 
-2236/+59)  was  transiently  transfected  in  B16  mouse 
melanoma  and  in  NIH3T3  fibroblasts.  Consistent  with 
previous reports (Kltippel et al., 1991; Bentley et al., 1994), 
expression  of luciferase  driven  by the  mouse  tyrosinase 
promoter was 50 times higher in B16 melanoma cells than 
in NIH3T3 cells (data not shown), demonstrating the pres- 
ence in this part of the promoter of regulatory elements 
accountable for cell-specific expression of mouse  tyrosi- 
nase gene. To study the effects of intracellular cAMP ele- 
vation  on  the  mouse  tyrosinase  promoter  activity,  B16 
cells  were  transiently  transfected  with  pMT2.2  and  ex- 
posed to forskolin, a direct activator of adenylate cyclase. 
We observed a  fourfold stimulation of luciferase activity 
after 6 h with forskolin. A much stronger stimulation of lu- 
ciferase activity (15-18-fold) was obtained after 24 h or 30 h 
forskolin treatment (Fig. 1 A). Next, we studied the effects 
of various melanogenic agents that also increased the in- 
tracellular cAMP level on mouse tyrosinase promoter ac- 
tivity. B16 melanoma cells were transfected with pMT2.2, 
and  then  treated  for 24  h  with  forskolin,  Cholera  toxin 
(CTx), o~MSH, IBMX or otMSH plus IBMX. CTx led to a 
10-fold  stimulation  of  the  luciferase  activity,  aMSH  or 
IBMX treatment caused a fivefold stimulation while o~MSH 
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Figure 1.  cAMP-elevating  agents stimulate the mouse tyrosinase 
promoter activity in B16 cells. B16 cells were transiently  trans- 
fected with pMT2.2, a plasmid which contains a 2.2-kb fragment 
5' of the transcriptional  start site of the mouse tyrosinase  gene 
cloned upstream the luciferase  coding sequence.  After transfec- 
tion, cells were incubated with 10 tzM forskolin for 6, 24, or 30 h 
(A), or with 1 p~M [Nle  4, D-Phe  7] ctMSH (ctMSH), 100 IxM IBMX, 
10 I~M cholera toxin (CTx), or ctMSH+IBMX for 24 h (B). Then, 
cells were solubilized  and  luciferase  activity  was  assayed.  Lu- 
ciferase  activity was normalized by the  ~-galactosidase  activity 
and the results were expressed as fold stimulation  of the basal lu- 
ciferase  activity  from  unstimulated  cells  (CONT).  Data  are 
means --_ SE of five experiments performed in triplicate. 
in combination with IBMX stimulated  about 17-fold the 
luciferase activity (Fig. 1 B). Stimulation of the mouse ty- 
rosinase promoter activity by cAMP elevating agents was 
also observed in $91 mouse melanoma cells and in G361 
human melanoma cells (Table I). Interestingly, similar ex- 
periments performed in NIH3T3 cells showed that a for- 
skolin  treatment  was  unable  to  stimulate  the  transcrip- 
tional activity of the mouse tyrosinase promoter (Table I), 
indicating that a cell type-specific mechanism triggers cAMP 
response in melanoma cells. These results indicate that the 
2.2-kb promoter fragment contains regulatory elements in- 
volved in the transcriptional regulation of the mouse tyro- 
sinase promoter by cAMP. 
Localization of cis-acting Elements Responsible for 
cAMP Response 
To identify the regulatory elements of the mouse tyrosi- 
nase promoter involved in the cAMP response, we con- 
structed  a  series of reporter plasmids containing various 
deletions in the 5'-flanking region of the promoter. Previ- 
ous reports demonstrated that the 270-bp 5' of the tran- 
scriptional start site was sufficient to direct pigment cell- 
specific expression but was unresponsive to intracellular 
cAMP elevation (Ganss et al.,  1994).  Hence, we studied 
the  effects of forskolin  on  deletion  constructs  spanning 
from 2.2 kb to 270 bp 5' of the transcriptional start site. 
After  transfection  with  pMT1.8  (-1789/+59),  pMT1.3 
(-1327/+59), pMTI.1 (-1100/+59), pMT0.9 (-986/+59), 
pMT0.5 (-517/+59), or pMT0.27 (-270/+59), a 24-h for- 
skolin  treatment stimulated  15-18-fold the  luciferase ac- 
tivity (Fig.  2 A). The responsiveness of all deletion  con- 
structs to forskolin was similar to that observed with the 
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Tyrosinase Promoter in Melanoma Cell Lines but Not in 
NIH3T3 
Fold stimulation 
Cell lines  induced by forskolin 
B16  20 -  2 
S91  22 ±  3 
G361  10 ±  1 
NIH3T3  1.5 ±  1 
Cells were transfected with pMT2.2, treated with forskolin for 24 h, and luciferase ac- 
tivity was measured. Results are means -  S.E. of three independent experiments done in 
triplicate. 
initial reporter plasmid pMT2.2. Also, in stably transfected 
B16 cells with pMT2.2 or pMT0.27, forskolin lead respec- 
tively to a 15 -+ 1 and 13 +  2 (mean +_ SE of three different 
experiments) fold increase in the tyrosinase promoter ac- 
tivity. These  results  indicate  that  cAMP  responsive  ele- 
ments are present in the 270-bp fragment of the promoter. 
In an attempt to further characterize these elements, we 
constructed  additional  deletions  in  tyrosinase promoter, 
pMT0.1 (-126/+59), pMT0.08 (-80/+59), pMT0.04 (-40/ 
+59), and pMTA0.1 corresponding to pMT0.1 in which the 
region between the HindIII (-80) restriction site and the 
TATA-box (-40) had been deleted. Luciferase activity of 
pMT0.1 was 17-fold stimulated by forskolin while, in the 
same  conditions,  after  transfection  with  pMT0.08  or 
pMT0.04,  forskolin caused only a  fivefold stimulation of 
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Figure2.  A cAMP regulatory element is localized between - 126 
and -80 in mouse tyrosinase promoter. B16 cells were transiently 
transfected with  pMT2.2,  pMT1.8,  pMT1.3,  pMTI.1, pMT0.9, 
pMT0.5, and pMT0.27 (A), or with pMT0.27, pMT0.1, pMT0.08, 
pMT0.04, and pMTA0.1 (B). After 24 h with forskolin, luciferase 
activity was assayed  as previously  described  and normalized by 
the [~-galactosidase activity. Numbers at the 5' end of each con- 
struct indicate the deletion endpoints relative to the transcription 
initiation site (+ 1  ). Triangles indicate the TATA-box position. In 
pMT~0.1, the hatched lines indicate that the region between -80 
and -40 has been deleted. Results are expressed as fold stimula- 
tion of the basal luciferase activity from unstimulated cells. Data 
are means + SE of five experiments performed in triplicate. 
luciferase activity, pMTA0.1  showed a  slightly decreased 
response  (14-fold)  to  forskolin  compared  with  pMT0.1 
(Fig. 2 B). All of these constructs had a similar basal activ- 
ity, except pMT0.08 and pMT0.04 which showed a fivefold 
decreased basal activity compared to the pMT2.2. These 
results suggest that important elements conferring cAMP 
responsiveness  to  mouse  tyrosinase  promoter  in  B16 
mouse melanoma cells are located between RsaI (-126) 
and HindIII (-80) restriction sites. 
Putative Enhancer Activity of cAMP Sensitive 
Regulatory Elements 
The putative enhancer activity of regulatory elements in- 
volved in  cAMP  response  of the  mouse  tyrosinase pro- 
moter  was  evaluated  using  an  enhancerless  expression 
vector containing the SV40 early promoter upstream from 
the luciferase coding sequence (pSV). Initially, we cloned 
the  2.2-kb  fragment (pSVMT2.2)  and  the  XbaI-HindIII 
(-270/-80) restriction fragment (pSVMT0.2) of the mouse 
tyrosinase promoter upstream the  SV40  early promoter. 
Furthermore the sequence of the region between RsaI and 
HindIII (-126/-80) restriction sites conferring the cAMP 
responsiveness  revealed  the  presence  of  a  GTCATGT- 
GCT motif (M-box). Thus, we introduced three copies of 
the M-box motif upstream the SV40 promoter into pSV 
(pSV3M).  After  transfection  with  pSV  and  pSV3M,  lu- 
ciferase activity was stimulated 2-3-fold by forskolin treat- 
ment (Fig. 3). With pSVMT2.2 and pSVMT0.2, the stimu- 
lation  evoked  by  forskolin  treatment  (fivefold)  was 
slightly increased, but this stimulation was markedly lower 
than that observed with pMT2.2. Taken together, these re- 
sults indicate  that the  cAMP regulatory elements of the 
mouse tyrosinase promoter do not act as remote enhancer 
elements to confer cAMP responsiveness. 
Identification of cis-acting Elements Involved in 
cAMP Response 
To thoroughly study the role of the GTCATGTGCT mo- 
tif (-120/-110)  in the cAMP responsiveness of the mouse 
tyrosinase promoter, mutations were introduced  into the 
core M-box and in its surrounding region in pMT0.1. Mu- 
tations of the three nucleotides upstream (M1)  or down- 
stream  (M4)  the  M-box sequence  and  mutations  of the 
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Figure 3.  The cis-acting elements involved in cAMP responsive- 
ness did not function as remote enhancer activity. B16 cells were 
transiently  transfected with pMT2.2, pSV, pSVMT2.2, pSVMTX/ 
H, or pSV3M. After 24 h with forskolin, luciferase activity was as- 
sayed as previously described and normalized by the [~-galactosi- 
dase activity.  Results  are expressed as fold  stimulation  of the 
basal luciferase activity from unstimulated cells. Data are means + 
SE of five experiments performed in triplicate. 
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pair the effect of forskolin on luciferase activity compared 
with the wild-type pMT0.1 (Fig. 4). Conversely, mutations 
in  the  first  three  nucleotides  (M2)  or  in  the  core  motif 
CATGTG  (M5)  of the  M-box  decreased  markedly  the 
cAMP response of the promoter (respectively, 9- and 5-fold 
stimulation). Also, when pMT2.2 containing the same mu- 
tated M-box (M6) was transfected, luciferase activity was 
only sixfold stimulated by forskolin treatment. The results 
show that this M-box plays a key role in cAMP responsive- 
ness of the mouse tyrosinase promoter. 
A  second CATGTG motif (E-box) was found 10 bp be- 
low the TATA-box near the initiator elements. Hence, we 
studied the effects of mutations in this region of the pro- 
moter on the cAMP response. Mutations in pMT0.1 of the 
nucleotides  upstream the E-box (El, E2)  did not impair 
the cAMP effect on the luciferase activity compared with 
the  wild-type  pMT0.1  (17-19-fold  stimulation)  (Fig.  5). 
Conversely,  the  cAMP  response  was  markedly reduced 
(sevenfold) when mutations were introduced immediately 
downstream the  CATGTG motif (E3)  but  unaffected in 
E4 mutant. Furthermore, mutations within the core E-box 
in both pMT0.1  (E5) and pMT2.2 (E6) led to a  dramatic 
decrease in the cAMP effect on luciferase activity (threefold 
stimulation). Double mutation of both M-box and initiator 
E-box  (iE-box)  in  pMT2.2  did  not  further  decrease  the 
cAMP response (threefold). These data indicate that this 
E-box is also involved in the cAMP responsiveness of the 
tyrosinase promoter. Additionally, it should be noted that 
mutation  of the  M-box,  or  of the  iE-box,  markedly de- 
creased the basal activity of the promoter (respectively, 
5- and 10-fold compared to pMT2.2) in B16 cells but in any 
case,  these  constructs  still  remained  much  more  active 
than a promoter less construct. In NIH3T3, all these con- 
structs were unresponsive to cAMP. However, mutations 
of the M-box or of the iE-box did not affect the basal ac- 
tivity of the promoter transfected in NIH3T3 cells. 
RELATIVE  LUCIFERASE  ACTIVITY, 
FOLD  STIMUL£TION 
V AGGaaacatl:Jtqataqtc  ~  E1  ~N~~NN~LI 
.  ccaTCCcatgtqatagtc  ~  E2  ~k~N~-q 
V ccaaaacat~ll:qGACqtc  ~  E3 
V ccaaaacatgt~at  aCAA  ----]El  E4  ~--~NN~l 
V ccaaaacGGAtCataqtc  ~  ES 
.~_j+~  V  ccaaaacatcdtqataqtc  ~  pMx2.2 ~~ 
_  V ccaaaacGGAtCataqtc  ~  E6  I~ 
Figure 5.  The initiator E-box is also involved in cAMP response 
of the mouse tyrosinase promoter. B 16 cells were transiently trans- 
fected with promoter constructs mutated at the core iE-box motif 
(pMT2.2 and pMT0.1)  or in its flanking  regions  (pMT0.1). B16 
cells were also transfected with pMT2.2 containing mutated M-box 
and iE-box. The nucleotides  mutated are indicated  in capital let- 
ters. After 24 h with forskolin, luciferase  activity was assayed as 
previously described and normalized by the 13-galactosidase  activ- 
ity.  Results  are  expressed as fold stimulation  of the  basal lu- 
ciferase activity from unstimulated  cells. Data are means -+ SE of 
five experiments performed in triplicate. 
Characterization of  anti-Microphthalmia Antibody 
In recent reports, a b-HLH protein named microphthalmia 
was suspected to be involved in tissue-specific expression 
of tyrosinase through its interaction with the CATGTG se- 
quences (Bentley et al., 1994; Hemesath et al., 1994; Yasu- 
moto et al.,  1994). To study the role of this transcription 
factor, we first raised an antibody against a peptide corre- 
sponding to the COOH terminus domain of microphthalmia. 
Immunofluorescence studies  showed  no  signal  with  this 
antibody  in  NIH3T3  cells  (Fig.  6  A).  However,  we  ob- 
served a strong labeling of the nucleus in NIH3T3 cells sta- 
bly  transfected  with  pCDNA3  encoding  microphthalmia 
RELATIVE  LUCIFERASE  ACTIVITY, 
FOLD STIMULATION 
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M2 
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Figure 4.  M-box  upstream  from  the  TATA-box is  involved in 
cAMP response. B16 cells were transiently transfected with pro- 
moter constructs mutated  at the core M-box motif (pMT2.2 and 
pMT0.1) or in its flanking regions (pMT0.1). The nucleotides mu- 
tated are indicated in capital letters. After 24 h with forskolin, lu- 
ciferase activity was assayed as previously described and normal- 
ized by the 13-galactosidase activity. Results are expressed as fold 
stimulation  of  the  basal  luciferase  activity  from  unstimulated 
cells. Data are means -+ SE of five experiments performed in trip- 
licate. 
Figure 6.  Immunolocalization of microphthalmia.  Immunofluo- 
rescence labeling was performed with the anti-microphthalmia anti- 
body.  Nontransfected  NIH3T3  cells  (A),  NIH3T3  cells  trans- 
fected with the expression plasmid encoding microphthalmia (B), 
unstimulated B16 mouse melanoma cells (C), and forskolin-stim- 
ulated B16 mouse melanoma cells (D). Bar in A represents 10 txm. 
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antibodies was also observed in B16 melanoma cells (C), 
and this labeling was not modified by forskolin treatment 
(D). Then, we performed a gel shift assay with the in vitro 
transcribed/translated microphthalmia using labeled M-box 
as  probe.  In  vitro  transcribed/translated  proteins  from 
pCDNA3  encoding  microphthalmia  formed  a  complex 
with the M-box. This complex was shifted by our antibody 
but unaffected by the preimmune serum. No complex was 
observed  with  in  vitro  transcribed/translated  reactions 
performed in the  absence of plasmid (Fig. 7), Taken to- 
gether these results demonstrate the specificity of our anti- 
microphthalmia antibody. 
Characterization of the Factor Interacting with cA3VIP 
Regulatory Elements of  the Mouse Tyrosinuse Promoter 
To  characterize  the  nuclear  factors interacting  with  the 
cAMP regulatory elements of the tyrosinase promoter, we 
performed  band  shift  assays  using  M-box  or  iE-box  as 
probes (Fig. 8). M-box and iE box formed one major com- 
plex with nuclear extracts from basal- and forskolin-treated 
B16. M-box and iE-box complexes were displaced by unla- 
beled probe but was unaffected by mutant oligonucleotide. 
Furthermore, the nature of proteins bound to the M-box 
and to the  iE-box was investigated by supershift experi- 
ments.  M-box or iE-box complexes formed with B16  or 
NIH3T3 nuclear extracts were partially shifted by USF an- 
tibodies (not shown). Using antibodies to microphthalmia 
(Fig.  9 A),  we  showed  that  M-box or iE-box complexes 
from NIH3T3 nuclear extracts did not react with these an- 
tibodies. Per contra, M-box or iE-box complexes from B16 
nuclear  extracts  were  partially  shifted  by  anti-micro- 
phthalmia  antibody  (Fig.  9  B).  Interestingly,  cAMP  in- 
creased  M-box or  iE-box complexes shifted  by anti-mi- 
crophthalmia antibody. Also, band shift assays performed 
using  immunopurified  microphthalmia  (Fig.  9  C)  con- 
firmed that cAMP increased the amount of microphthalmia 
complexed to the  M-box or the iE-box. Taken together, 
these data demonstrate that microphthalmia is a B16 mel- 
anoma  cell-specific transcription  factor  and  that  cAMP 
stimulates the binding of microphthalmia to its target se- 
quences. 
To further investigate the role of microphthalmia in the 
effect of cAMP on tyrosinase promoter, we cotransfected 
an expression vector encoding microphthalmia with pM'IE.2 
and pMT0.1. Microphthalmia induced a dramatic increase 
Figure 8.  M-box and the iE-box-binding activities are present in 
B16 nuclear extracts. DNA-binding activity of 10 ~g nuclear pro- 
teins from control, C, or forskolin-treated B16 cells was measured 
by gel mobility shift assay using labeled M-box or iE-box. Speci- 
ficity of the complexes was tested by competition with increasing 
molar excess (3×, 10×, 50×) of unlabeled M-box or iE-box and 
with increasing molar excess (10 x, 50 x) of mutated M-box (mM- 
box) or iE-box (miE-box). 
in the luciferase activity. This effect on basal transcription 
did not allow us to observe further stimulation when mi- 
crophthalmia-transfected cells were treated with forskolin 
(not shown). Moreover, we carried out a study to compare 
the  effect of microphthalmia on  the  different  tyrosinase 
promoter constructs with their cAMP responsiveness. For 
this purpose, both parameters were represented on a  sin- 
gle graph, cDNA encoding microphthalmia and different 
tyrosinase promoter constructs were cotransfected in B16 
melanoma cells and the effect of rnicrophthalmia expres- 
sion, on the basal transcriptional activity of the constructs, 
Figure 7.  Anti-microphthalmia 
antibody recognizes  in  vitro 
translated  microphthalmia. 
Transcription/translation  was 
performed either in the pres- 
ence of pCDNA3 encoding mi- 
crophthalmia (lanes 1--4) or in 
the absence of plasmid (lane 
5).  The transcription/transla- 
tion mix was used in a gel shift 
assay  with  labeled  M-box. 
Lanes 1 and 5, no serum; lanes 
2 and 3, respectively, 0.3 and 1 ~1 of anti-mierophthalmia  serum; 
lane 4, 1 I~1 of preimmune serum. 
Figure 9.  Microphthalmia  is a  B16-specific transcription  factor 
that binds to M-box and iE-box. Gel shift assays were performed 
using  labeled  M-box or  iE-box.  (A)  NIH3T3 nuclear  extracts 
were incubated for I h with 1 ~1 of preimmune serum (P/) or spe- 
cific antibodies  against microphthalmia (a-MI). (B) B16 nuclear 
extracts from control (-) or forskolin-treated cells (+) were in- 
cubated for 1 h with 1 p,l of preimmune serum (P/) or specific an- 
tibodies against microphthalmia (~-MI). (C) B16 nuclear extracts 
from control (-) or forskolin-treated cells (+) were immunopre- 
cipitated with  the  anti-microphthalmia  antibody,  and then mi- 
crophthalmia was eluted with 10 I~M of COOH terminus peptide. 
Specificity of the complexes was tested by competition with mo- 
lar excess of unlabeled M-box or iE-box (*). 
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these different constructs as determined in Figs. 4 and 5, 
was reported on the Y  axis. This drawing  allowed us to 
identify two groups of constructs (Fig. 10). In the first one 
the  constructs  showed  a  strong stimulation  of the  basal 
transcriptional activity (25-45-fold) in the presence of mi- 
crophthatmia and a  strong responsiveness to cAMP (17- 
24-fold). In the second group, the effect of microphthalmia 
(3-13-fold) and the cAMP responsiveness (3-8-fold) were 
markedly decreased.  Hence, it appears that the effect of 
cAMP on the tyrosinase promoter activity correlates with 
the ability of microphthalmia to bind and transactivate the 
promoter. 
Discussion 
cAMP elevating agents  stimulate melanogenesis through 
an  augmentation  of tyrosinase  mRNA.  However,  it  re- 
mains  to  elucidate  whether  cAMP  stabilizes  tyrosinase 
messenger or stimulates transcriptional activity of tyrosi- 
nase gene promoter. In the present report, we cloned  a 
2.2-kb fragment (-2236/+56)  of the tyrosinase promoter 
upstream from the luciferase coding sequence  (pMT2.2). 
Using this construct in transient transfection assays in B16 
melanoma cells, we showed that melanogenic agents that 
increase cAMP level stimulate the transcriptional activity 
of the mouse tyrosinase promoter. This observation dem- 
onstrates that this fragment of the promoter contains regu- 
latory elements involved in the cAMP response.  Recent 
studies have tentatively characterized the regulatory ele- 
ments involved in tissue-specific expression of the mouse 
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Figure 10.  Transactivation by microphthalmia correlates with the 
cAMP responsiveness  of the different promoter constructs.  Bt6 
cells were transiently  cotransfected with 0.04 I~g of pCDNA3 en- 
coding microphthalmia and 0.25 t~g of different tyrosinase pro- 
moter constructs.  After 24 h, luciferase  activity was assayed as 
previously described and normalized by the fi-galactosidase activ- 
ity. Results  are represented on the X axis as fold stimulation  of 
the basal luciferase  activity  in the absence of microphthalmia. 
Data are a mean of two separate experiments. On the Y axis are 
the effects of forskolin on the luciferase activity after transfection 
with the different constructs as indicated in Figs. 4 and 5. 
tyrosinase promoter (Ganss  et  al.,  1994;  Lowings et  al., 
1992; Yokoyama et al., 1994). On the other hand, the re- 
sponsive elements implicated in the acute regulation of ty- 
rosinase expression by cAMP elevating agents remain to 
be identified. Experiments using deletion constructs of the 
pMT2.2 showed that the 270-bp promoter fragment 5' of 
the transcription start site is highly responsive to cAMP in 
both transiently or stably transfected B16 cells. This obser- 
vation is contradictory with a recent report indicating that 
the same promoter fragment was unresponsive to cAMP 
(Ganss et al.,  1994). The reasons of this discrepancy ap- 
pear difficult to understand since Ganss et al. (1994) used 
B16 melanoma cell line in which cAMP increase the ex- 
pression of endogenous tyrosinase messengers. 
Additional deletions in the tyrosinase promoter showed 
that the cAMP response is dramatically reduced when the 
region spanning from -126  to  -80 is removed. The ab- 
sence in  this  region  of canonical  cAMP  responsive  ele- 
ments  (CRE)  and  of AP2-binding  site,  which  was  also 
shown to be responsive to cAMP (Imagawa et al., 1987), 
indicates that cAMP induces the stimulation of tyrosinase 
gene  expression  through  undiscovered  regulatory  ele- 
ments.  Introduction  of mutations in  the  fragment  -126/ 
-80 showed that the M-box and especially the core motif 
CATGTG are required for a full cAMP response of the ty- 
rosinase promoter. Nevertheless, a 6-8-fold stimulation of 
luciferase activity was still observed in these mutants, sug- 
gesting that other regulatory elements involved in cAMP 
response might exist. Indeed, when mutations were intro- 
duced in the CATGTG motif of the initiator E-box (iE- 
box) only a threefold stimulation of the luciferase activity 
was obtained. Interestingly, mutations of both M-box and 
iE-box did not lead to a further decrease in the cAMP re- 
sponse compared to  the  iE-box single  mutant.  Further- 
more, a weak effect of cAMP was observed on SV40 and 
on  thymidine  kinase  promoters  (threefold),  suggesting 
that the  residual  effect of cAMP on the  double  mutant 
could be ascribed to an effect of cAMP on general tran- 
scription. However, this effect remains very low compared 
to the specific effect of cAMP on tyrosinase expression. 
Taken together these data indicate that M-box and iE-box 
are  involved  in  the  stimulation  of  tyrosinase  promoter 
transcriptional activity by cAMP. These two elements act 
in  synergy  to  give  the  tyrosinase  promoter  its  strong 
cAMP  sensitivity.  Additionally,  we  cannot  rule  out  the 
possibility that other elements of the tyrosinase promoter 
(between -126/+ 1) cooperate with M-box and iE-box. 
The core motif CATGTG found in the M-box and in the 
iE-box was reported to interact with b-HLH transcription 
factors.  Yet,  until  now it was  not  possible to  identify  a 
transcription factor specific of melanoma cells since USF, 
an ubiquitously expressed b-HLH transcription factor, was 
shown to interact in vitro with the M-box (Yavuzer and God- 
ing, 1994). The binding of USF to the M-box could be as- 
cribed to the extreme avidity of USF for all the CANNTG 
motifs and might not be relevant in intact cells. In this re- 
port, immunofluorescence studies show that microphthalmia 
is expressed in B16 melanoma cells but not in NIH3T3 cells, 
in which  cAMP does not  affect the tyrosinase promoter 
activity.  Using  an  antibody  to  microphthalmia  in  band 
shift experiments we demonstrated that microphthalmia is 
a B16 melanoma cell-specific transcription factor. Further- 
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M-box  and to the iE-box.  The  augmentation of the mi- 
crophthalmia binding to its target sequences does not ap- 
pear to be the consequence of an increased amount of mi- 
crophthalmia. Indeed immunofluorescence labeling of B16 
cells was not affected by cAMP. Thus, it is conceivable that 
cAMP  stimulates  the  affinity  of microphthalmia  for  the 
CATGTG motifs via posttranslational modifications. This 
could  be  achieved  through  the  phosphorylation  of  mi- 
crophthalmia by PKA or unidentified kinases.  Addition- 
ally, the binding of microphthalmia to its target sequence 
could be regulated by its association with other proteins 
such  as  the  retinoblastoma  protein  (pRB).  Indeed,  mi- 
crophthalmia has been recently shown to interact with pRB 
(Yavuzer et al., 1995), and the phosphorylation of pRB has 
been reported to be inhibited by cAMP (Christofersenn et 
al., 1994). Thus, pRB  could interact with microphthalmia 
in a phosphorylation-dependent manner and regulate mi- 
crophthalmia binding. Finally, the correlation between the 
cAMP responsiveness of the different constructs and their 
transactivation by microphthalmia suggests  that an inter- 
action of microphthalmia with these cis-acting elements is 
required for the cAMP response. This result is in agree- 
ment with a  recent report indicating that MITF,  the hu- 
man homologue of microphthalmia, transactivates the ty- 
rosinase  promoter  through CATGTG  motifs  surrounding 
the TATA-box (Yasumoto et al., 1995). 
Taken together our results suggest that microphthalmia 
is involved in the regulation of the tyrosinase gene expres- 
sion by cAMP. Hence, it was tempting to propose that the 
lack  of  cAMP  effect  on  the  tyrosinase  promoter  in 
NIH3T3  cell  was due to the absence  of microphthalmia. 
However,  cAMP was still unable to stimulate the tyrosi- 
nase  promoter  activity  in  NIH3T3  cells  expressing  mi- 
crophthalmia (not shown). This result suggests that a B16 
cell-specific signaling pathway is missing in NIH3T3 cells. 
Indeed it should be noted that cAMP was reported to in- 
hibit the activation of MAP kinases in NIH3T3 cells (Bur- 
gering  et  al.,  1993).  On  the  contrary, in B16  melanoma 
cells  we  have  shown  that cAMP  activated  MAP  kinase 
(ERK1) and induced its translocation to the nucleus (En- 
glaro et al., 1995). The presence in microphthalmia of con- 
sensus sequence for MAP kinase phosphorylation (P-x-T/ 
S-P) led us to propose that MAP kinases could phosphory- 
late  and  activate  microphthalmia  in  the  nucleus  of B16 
cells. This hypothesis is currently under investigation. 
In summary, we demonstrated in this report that tyrosi- 
nase promoter was responsive to cAMP.  Two CATGTG 
motifs surrounding the TATA-box are involved in this re- 
sponse and convey microphthalmia transactivating effect. 
Since we have shown that the binding of microphthalmia 
to these motifs  is stimulated by cAMP,  we hypothesized 
that microphthalmia is involved in the regulation of tyrosi- 
nase promoter by cAMP. 
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